[DOI] [PubMed] [Google Scholar] 27.Kosiborod M.N., Petrie M.C., Borlaug B.A
Evol Med Public Health
Currently, there are other dual GIPR/GLP-1R agonists available, such as GLP-1R/GR (glucagon receptor), GLP-1R/AR (amylin receptor), and GLP-1R/NPYR (peptide YY binds to neuropeptide Y receptors) [36, 115] and even triple agonists that can activate GIPR to treat obesity and T2DM
Despite the possibility of withholding all food for 48 hours before the appointment, patients may experience difficulty adhering to the restriction and may experience hypoglycemia during conscious sedation
For patients with type 2 diabetes, GLP-1 medications are generally considered long-term therapy as part of individualized disease management
Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2021